David Guzo

Array ( [id] => 996488 [patent_doc_number] => 06913927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-05 [patent_title] => 'Non-adenoviral gene product-based complementing cells for adenoviral vectors' [patent_app_type] => utility [patent_app_number] => 10/695605 [patent_app_country] => US [patent_app_date] => 2003-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8636 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/913/06913927.pdf [firstpage_image] =>[orig_patent_app_number] => 10695605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7151970 [patent_doc_number] => 20040171826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Endomannosidases in the modification of glycoproteins in eukaryotes' [patent_app_type] => new [patent_app_number] => 10/695243 [patent_app_country] => US [patent_app_date] => 2003-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 21998 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171826.pdf [firstpage_image] =>[orig_patent_app_number] => 10695243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469163 [patent_doc_number] => 20040102411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'DNA vaccine against feline immunodeficiency virus' [patent_app_type] => new [patent_app_number] => 10/673008 [patent_app_country] => US [patent_app_date] => 2003-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21814 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102411.pdf [firstpage_image] =>[orig_patent_app_number] => 10673008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7349404 [patent_doc_number] => 20040047878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'DNA vaccine against feline immunodeficiency virus' [patent_app_type] => new [patent_app_number] => 10/672489 [patent_app_country] => US [patent_app_date] => 2003-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21820 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20040047878.pdf [firstpage_image] =>[orig_patent_app_number] => 10672489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7164827 [patent_doc_number] => 20040076632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'DNA vaccine against feline immunodeficiency virus' [patent_app_type] => new [patent_app_number] => 10/673023 [patent_app_country] => US [patent_app_date] => 2003-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21738 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20040076632.pdf [firstpage_image] =>[orig_patent_app_number] => 10673023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 630447 [patent_doc_number] => 07132407 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-07 [patent_title] => 'DNA vaccine containing tumor-associated gene and cytokine gene and method of preparation the same' [patent_app_type] => utility [patent_app_number] => 10/663048 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 2660 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/132/07132407.pdf [firstpage_image] =>[orig_patent_app_number] => 10663048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7428849 [patent_doc_number] => 20040161847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Vigilant vector system' [patent_app_type] => new [patent_app_number] => 10/659621 [patent_app_country] => US [patent_app_date] => 2003-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12595 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20040161847.pdf [firstpage_image] =>[orig_patent_app_number] => 10659621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7335176 [patent_doc_number] => 20040132181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Trans-splicing mediated photodynamic therapy' [patent_app_type] => new [patent_app_number] => 10/658617 [patent_app_country] => US [patent_app_date] => 2003-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 15021 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132181.pdf [firstpage_image] =>[orig_patent_app_number] => 10658617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7269929 [patent_doc_number] => 20040058447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Gene transfer methods' [patent_app_type] => new [patent_app_number] => 10/657076 [patent_app_country] => US [patent_app_date] => 2003-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15747 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058447.pdf [firstpage_image] =>[orig_patent_app_number] => 10657076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7405480 [patent_doc_number] => 20040105845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'AAV vectors for gene therapy' [patent_app_type] => new [patent_app_number] => 10/656474 [patent_app_country] => US [patent_app_date] => 2003-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 18329 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20040105845.pdf [firstpage_image] =>[orig_patent_app_number] => 10656474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 884260 [patent_doc_number] => 07351585 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-01 [patent_title] => 'Retroviral vector' [patent_app_type] => utility [patent_app_number] => 10/654537 [patent_app_country] => US [patent_app_date] => 2003-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 25 [patent_no_of_words] => 25264 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/351/07351585.pdf [firstpage_image] =>[orig_patent_app_number] => 10654537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275670 [patent_doc_number] => 20040235121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'High copy number plasmids and their derivatives' [patent_app_type] => new [patent_app_number] => 10/651654 [patent_app_country] => US [patent_app_date] => 2003-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10619 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235121.pdf [firstpage_image] =>[orig_patent_app_number] => 10651654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7673339 [patent_doc_number] => 20040180440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Modified AAV' [patent_app_type] => new [patent_app_number] => 10/651828 [patent_app_country] => US [patent_app_date] => 2003-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16145 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180440.pdf [firstpage_image] =>[orig_patent_app_number] => 10651828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281546 [patent_doc_number] => 20040063923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Molecular differences between species of the M. tuberculosis complex' [patent_app_type] => new [patent_app_number] => 10/647089 [patent_app_country] => US [patent_app_date] => 2003-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11412 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063923.pdf [firstpage_image] =>[orig_patent_app_number] => 10647089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 884904 [patent_doc_number] => 07351792 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-01 [patent_title] => 'Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor' [patent_app_type] => utility [patent_app_number] => 10/643627 [patent_app_country] => US [patent_app_date] => 2003-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 20 [patent_no_of_words] => 11993 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/351/07351792.pdf [firstpage_image] =>[orig_patent_app_number] => 10643627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7304536 [patent_doc_number] => 20040115816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Method of modifying the genome of gram-positive bacteria by means of a novel conditionally negative dominant marker gene' [patent_app_type] => new [patent_app_number] => 10/467479 [patent_app_country] => US [patent_app_date] => 2003-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5852 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115816.pdf [firstpage_image] =>[orig_patent_app_number] => 10467479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 754130 [patent_doc_number] => 07018835 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-28 [patent_title] => 'Recombinant double-stranded RNA phage, and use of the same' [patent_app_type] => utility [patent_app_number] => 10/632094 [patent_app_country] => US [patent_app_date] => 2003-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17412 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/018/07018835.pdf [firstpage_image] =>[orig_patent_app_number] => 10632094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7295896 [patent_doc_number] => 20040214193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Method for assessing recording in vitro and in vivo' [patent_app_type] => new [patent_app_number] => 10/627588 [patent_app_country] => US [patent_app_date] => 2003-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11756 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214193.pdf [firstpage_image] =>[orig_patent_app_number] => 10627588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7400139 [patent_doc_number] => 20040023393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Micellar systems' [patent_app_type] => new [patent_app_number] => 10/627247 [patent_app_country] => US [patent_app_date] => 2003-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15672 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023393.pdf [firstpage_image] =>[orig_patent_app_number] => 10627247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5739227 [patent_doc_number] => 20060009618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Expression receptors with 7 transmembrane domains in baculovirus-insect cell system' [patent_app_type] => utility [patent_app_number] => 10/522124 [patent_app_country] => US [patent_app_date] => 2003-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6418 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009618.pdf [firstpage_image] =>[orig_patent_app_number] => 10522124 [rel_patent_id] =>[rel_patent_doc_number] =>)